These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 24298915)
41. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris]. Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692 [TBL] [Abstract][Full Text] [Related]
42. Atovaquone-proguanil for prophylaxis and treatment of malaria. Marra F; Salzman JR; Ensom MH Ann Pharmacother; 2003 Sep; 37(9):1266-75. PubMed ID: 12921511 [TBL] [Abstract][Full Text] [Related]
43. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD; Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385 [TBL] [Abstract][Full Text] [Related]
45. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis. Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510 [TBL] [Abstract][Full Text] [Related]
46. [A collective malarial infestation during a humanitarian mission in west Africa]. Philippe JM; Caumon L; Chouaki M; Dufraise S; Rimeize H; Monchard F; Cueto T; Beytout J; Delort P Bull Soc Pathol Exot; 2002 Jun; 95(2):71-3. PubMed ID: 12145960 [TBL] [Abstract][Full Text] [Related]
47. Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases. Cordel H; Cailhol J; Matheron S; Bloch M; Godineau N; Consigny PH; Gros H; Campa P; Bourée P; Fain O; Ralaimazava P; Bouchaud O Malar J; 2013 Nov; 12():399. PubMed ID: 24200190 [TBL] [Abstract][Full Text] [Related]
48. Further observation of travellers taking twice-weekly atovaquone-proguanil prophylaxis in sub-Saharan Africa. Biber A; Harel R; Schwartz E J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30690466 [No Abstract] [Full Text] [Related]
49. Evaluation of mood profiles during malaria chemoprophylaxis: a randomized, double-blind, four-arm study. Schlagenhauf P; Johnson R; Schwartz E; Nothdurft HD; Steffen R J Travel Med; 2009; 16(1):42-5. PubMed ID: 19192127 [TBL] [Abstract][Full Text] [Related]
50. Quality of travel health advice in a French travel medicine and vaccine center: a prospective observational study. Bouldouyre MA; De Verdière NC; Pavie J; De Castro N; Ponscarme D; Hamane S; Rachline A; Ferret S; Molina JM J Travel Med; 2012; 19(2):76-83. PubMed ID: 22414031 [TBL] [Abstract][Full Text] [Related]
51. Malaria prevention recommendations for risk groups visiting sub-Saharan Africa: A survey of European expert opinion and international recommendations. Shellvarajah M; Hatz C; Schlagenhauf P Travel Med Infect Dis; 2017 Sep; 19():49-55. PubMed ID: 28939502 [TBL] [Abstract][Full Text] [Related]
52. Choice of and adherence to prophylactic antimalarials. Goodyer L; Rice L; Martin A J Travel Med; 2011; 18(4):245-9. PubMed ID: 21722235 [TBL] [Abstract][Full Text] [Related]
53. Patterns of imported malaria at the academic medical center, Amsterdam, the Netherlands. Baas MC; Wetsteyn JC; van Gool T J Travel Med; 2006; 13(1):2-7. PubMed ID: 16412103 [TBL] [Abstract][Full Text] [Related]
54. Efficacy and safety of atovaquone/proguanil as suppressive prophylaxis for Plasmodium falciparum malaria. Shanks GD; Gordon DM; Klotz FW; Aleman GM; Oloo AJ; Sadie D; Scott TR Clin Infect Dis; 1998 Sep; 27(3):494-9. PubMed ID: 9770146 [TBL] [Abstract][Full Text] [Related]
55. Relapsing vivax malaria after 6 months of daily atovaquone/proguanil in Afghanistan: the case for expanded use of primaquine as a causal prophylactic. Maguire JD; Llewellyn DM J Travel Med; 2007; 14(6):411-4. PubMed ID: 17995538 [TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of atovaquone-proguanil in treating imported malaria in Japan: the second report from the research group. Kimura M; Koga M; Kikuchi T; Miura T; Maruyama H Parasitol Int; 2012 Sep; 61(3):466-9. PubMed ID: 22484597 [TBL] [Abstract][Full Text] [Related]
57. Plasmodium falciparum malaria occurring four years after leaving an endemic area. Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505 [TBL] [Abstract][Full Text] [Related]
58. Clinical pharmacology of atovaquone and proguanil hydrochloride. Beerahee M J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547 [TBL] [Abstract][Full Text] [Related]
59. Artemether + lumefantrine: new drug. An alternative to atovaquone + proguanil. Prescrire Int; 2008 Apr; 17(94):54-6. PubMed ID: 18516806 [TBL] [Abstract][Full Text] [Related]
60. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]